# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-052351
Filing Date
2022-04-28
Accepted
2022-04-28 16:45:43
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm223513d2_defa14a.htm | DEFA14A | 13141
2 | GRAPHIC | tm223513d2_defa14aimg001.jpg | GRAPHIC | 449017
3 | GRAPHIC | tm223513d2_defa14aimg002.jpg | GRAPHIC | 415866
| Complete submission text file | 0001104659-22-052351.txt |  | 1205623

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37990 | Film No.: 22867470
SIC: 2834 Pharmaceutical Preparations